Home Stock

Stock Research: Uniphar

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Uniphar

ISE:UPR IE00BJ5FQX74
60
  • Value
    51
  • Growth
    43
  • Safety
    Safety
    53
  • Combined
    51
  • Sentiment
    72
  • 360° View
    360° View
    60
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Uniphar PLC is an Ireland-based diversified healthcare service company focused on improving access to pharmaco-medical products and therapies. It operates through Uniphar Medtech (outsourced services to medical device manufacturers), Uniphar Pharma (global services across pharmaceutical product lifecycle), and Uniphar Supply Chain & Retail (pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products) with pharmacy brands like Life, Allcare, Hickey’s, and McCauleys. It primarily operates in Ireland, with its Pharma division having a global presence. In the last fiscal year, the company had 3514 employees, a market cap of $1045 millions, profits of $443 millions, and revenue of $2868 millions.

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Price vs. Book (P/B)
Country Ireland
Industry Health Care Distributors
Size Medium
Website uniphar.ie
Index
ISEQ
Sound Pay Europe
Uniphar stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 62 60 53
Growth
43 8 19 99
Safety
Safety
53 20 16 20
Sentiment
72 68 42 21
360° View
360° View
60 18 10 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
63 71 79 89
Opinions Change
65 50 50 18
Pro Holdings
n/a 67 16 6
Market Pulse
57 45 59 32
Sentiment
72 68 42 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 62 60 53
Growth
43 8 19 99
Safety Safety
53 20 16 20
Combined
51 4 10 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
72 85 83 77
Price vs. Earnings (P/E)
20 59 53 33
Price vs. Book (P/B)
87 91 84 82
Dividend Yield
34 30 24 26
Value
51 62 60 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
52 17 39 65
Profit Growth
43 49 50 74
Capital Growth
28 4 34 77
Stock Returns
83 24 23 99
Growth
43 8 19 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
43 28 24 22
Refinancing
42 15 15 13
Liquidity
40 29 40 42
Safety Safety
53 20 16 20

Similar Stocks

Discover high‑ranked alternatives to Uniphar and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Fagron

BRU:FAGR
Country: Belgium
Industry: Health Care Distributors
Size: Medium
Full Stock Analysis

Ambea

STO:AMBEA
Country: Sweden
Industry: Health Care Facilities
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews